Published in Fertil Steril on September 01, 1971
Hormonal contraception--what kind, when, and for whom? Dtsch Arztebl Int (2011) 2.47
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43
Clinical assessment of a low-oestrogen combined oral contraceptive. Br Med J (1973) 2.32
Diagnosis and management of dysmenorrhoea. BMJ (2006) 1.43
The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest (1998) 1.01
Ethics of health research in communities: perspectives from the southwestern United States. Ann Fam Med (2010) 0.96
Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception (2012) 0.93
An exploratory analysis of associations between eating disordered symptoms, perceived weight changes, and oral contraceptive discontinuation among young minority women. J Adolesc Health (2012) 0.75
Analyzing data from ordered categories. N Engl J Med (1984) 4.40
Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making (1994) 2.65
Reliability of psychiatrists' ratings in community case finding. Am J Public Health Nations Health (1967) 2.64
Institutional differences in Postoperative death rates. Commentary on some of the findings of the National Halothane Study. JAMA (1968) 2.15
Statistical approaches to classification. Methods for developing classification and other criteria rules. Arthritis Rheum (1990) 1.89
Graphical methods in statistical analysis. Annu Rev Public Health (1987) 1.85
Reliability of newly trained raters in community case finding. Am J Public Health Nations Health (1967) 1.71
Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol. J Reprod Med (1983) 1.45
Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol (1985) 1.36
Study of norethindrone in contraception. JAMA (1962) 1.26
Return of ovulation after discontinuance of oral contraceptives. Fertil Steril (1967) 1.13
Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use. Obstet Gynecol (1985) 1.07
Spectrum of nonpuerperal galactorrhea: report of two cases evolving through the various syndromes. J Clin Endocrinol Metab (1967) 1.05
Thoracic CT images: effect of lossy image compression on diagnostic accuracy. Radiology (1994) 1.04
Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. J Clin Oncol (2000) 1.03
Improving the diagnostic reliability of rapidly fluctuating plasma hormone levels by optimized multiple-sampling techniques. J Clin Endocrinol Metab (1976) 1.03
A validity study using the Leighton instrument. Am J Public Health (1971) 0.97
The series of consecutive cases as a device for assessing outcomes of intervention. N Engl J Med (1984) 0.93
Morphology of the cervix in women treated with synthetic progestins. Am J Obstet Gynecol (1966) 0.92
Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study. Am J Obstet Gynecol (1971) 0.91
Oral contraceptive hazards--1981. Fertil Steril (1981) 0.90
Fertility control with long-acting injectable steroids. A preliminary report. Obstet Gynecol (1966) 0.90
American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract (2003) 0.89
Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine. Proc Natl Acad Sci U S A (1992) 0.89
The urinary metabolites of 17alpha-ethynylestradiol-9alpha,11xi-3H in women. Chromatographic profiling and indentification of ethynyl and non-ethynyl compounds. Steroids (1975) 0.89
Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations. Steroids (1980) 0.88
Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives. Am J Obstet Gynecol (1970) 0.88
Polycystic ovarian disease. Fertil Steril (1981) 0.88
Tree-structured vector quantization of CT chest scans: image quality and diagnostic accuracy. IEEE Trans Med Imaging (1993) 0.88
Plasma levels and pharmacokinetics of ethynyl estrogens in various populations: II. Mestranol. Contraception (1980) 0.88
Human urinary and liver conjugates of 17alpha-ethnylestradiol. Steroids (1976) 0.87
Gross Cerebral Hemorrhage and Vascular Lesions in Acute Tuberculous Meningitis and Meningo-Encephalitis. Am J Pathol (1947) 0.87
Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol. Contraception (1980) 0.87
Continuous tablet therapy for oral contraception. Obstet Gynecol (1968) 0.86
Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower? Contraception (1989) 0.86
Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. Med Pediatr Oncol (2000) 0.85
Pharmacokinetics of ethynyloestradiol in women for different populations. Contraception (1981) 0.85
Statistical concepts fundamental to investigations. N Engl J Med (1985) 0.85
The pharmacokinetics and metabolism of ethinyl estradiol and its three sulfates in the baboon. Am J Obstet Gynecol (1983) 0.85
Relation of parity to age at menopause. Am J Obstet Gynecol (1966) 0.85
Urinary excretion of gonadotropins in congenital adrenal hyperplasia. Pediatrics (1968) 0.85
A note on the Wilcoxon-Mann-Whitney test for 2 X kappa ordered tables. Biometrics (1985) 0.84
Metabolism of ethynyl estrogens. J Toxicol Environ Health (1977) 0.84
The polycystic ovary. VI. A hilus cell tumour of the ovary associated with polycystic ovarian disease: in vivo and in vitro studies. Acta Endocrinol (Copenh) (1966) 0.83
Oral contraceptives and thromboembolism: a reassessment. Am J Obstet Gynecol (1975) 0.83
Experimentally induced accumulation of Foxp3⁺ T cells in upper airway allergy. Clin Exp Allergy (2011) 0.82
Hormone-induced alterations of ovarian morphology. Fertil Steril (1966) 0.82
Polycystic ovarian disease. Clin Obstet Gynecol (1973) 0.82
Oral contraceptives and thromboembolism. JAMA (1969) 0.82
Induction of degenerative changes in uterine myomas by high-dosage progestin therapy. Am J Obstet Gynecol (1966) 0.82
The pharmacokinetics of ethynyl estrogens. A review. Contraception (1977) 0.82
Plasma androgens during early pregnancy in the baboon (Papio cynocephalus). Fertil Steril (1983) 0.81
Pharmacokinetics of ethynyl estradiol: a current view. Contraception (1985) 0.80
Induction of ovulation and term pregnancy in a hypophysectomized woman. A case report. Obstet Gynecol (1972) 0.80
A simplified gas chromatographic method for large numbers of urinary pregnanediol determinations. Am J Obstet Gynecol (1967) 0.79
Inhibition by adrenocorticotrophin of gonadotrophin-induced ovulation in immature female rats. Endocrinology (1969) 0.79
Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency. Am J Obstet Gynecol (1975) 0.79
The mechanism of ovulation inhibition by triamcinolone acetonide. J Clin Endocrinol Metab (1978) 0.79
Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Fertil Steril (1978) 0.79
Extracorporeal membrane differential filtration--a new and safe method to optimize hemorheology in acute ischemic stroke. Acta Neurol Scand (1998) 0.78
The polycystic ovary. V. Alternate pathways of steroid aromatization in normal, pregnancy and polycystic ovaries. J Clin Endocrinol Metab (1965) 0.78
Limits of detection and quantification, as applied to an assay for digoxin. Clin Chem (1984) 0.78
Physiological cost in 36-and 48-hour simulated flights. Aerosp Med (1973) 0.78
The relationship of estrogen to placental steroidogenesis in the baboon. J Clin Endocrinol Metab (1986) 0.78
Evaluation of the OvuSTICK urinary luteinizing hormone kit in normal and stimulated menstrual cycles. Obstet Gynecol (1986) 0.78
Estrogens in oral contraceptives: historical perspectives. Johns Hopkins Med J (1982) 0.78
The metabolism of [4-14C] progesterone by hypertrophic and carcinomatous human prostate tissue. Biochim Biophys Acta (1965) 0.78
Metabolic balance studies with norethynodrel and chlormadinone acetate. Am J Obstet Gynecol (1967) 0.77
Relative rates of 2- and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. FEBS Lett (1982) 0.77
Management of menopause when estrogen cannot be used. Drugs (1990) 0.77
Immunologic thrombocytopenic purpura and pregnancy: six new cases. Obstet Gynecol (1978) 0.77
Metabolism of 11-beta-hydroxyandrostenedione, adrenosterone and hydrocortisone to urinary 11-oxy 17-ketosteroids. J Clin Endocrinol Metab (1969) 0.77
Biosynthesis of 11 -hydroxyandrostenedione by human and baboon adrenals. Acta Endocrinol (Copenh) (1973) 0.76
Perspectives in evaluating the safety and effectiveness of steroidal contraceptives in different parts of the world. Int J Gynaecol Obstet (1977) 0.76
Diagnosis of menopause: ratios of FSH/LH? Fertil Steril (1996) 0.76
How the oral contraceptives came to be developed. JAMA (1974) 0.76
When is it safe to switch from oral contraceptives to hormonal replacement therapy? Contraception (1995) 0.76
The history of steroidal contraceptive development: the estrogens. Perspect Biol Med (1993) 0.76
Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration. Contraception (1975) 0.76
Radioimmunoassay of plasma androstenedione, testosterone and 11beta-hydroxyandrostenedione after chromatography on Lipidex-5000 (hydroxyalkoxypropyl Sephadex). J Steroid Biochem (1978) 0.76
Synthesis of new steroid haptens for radioimmunoassay--VI. 3-O-Carboxymethyl ether derivatives of equine estrogens. Highly specific antisera for measurement of equilin and 17 alpha-dihydroequilin in plasma. J Steroid Biochem (1980) 0.76
Plasma gonadotropin-releasing hormone profiles after intravenous and subcutaneous bolus injection in thin and obese women. Obstet Gynecol (1988) 0.75
Luteal phase deficiency. Fertil Steril (1989) 0.75
Oral contraceptive use and breast cancer. Br J Cancer (1987) 0.75
Cardiovascular disease in women. Circulation (1994) 0.75
Separation of free and bound steroid in the competitive protein binding assay for testosterone: accuracy and reproducibility. Steroids (1971) 0.75
Large-scale study of an oral contraceptive. Fertil Steril (1969) 0.75
[Side effects of contraceptive steroids]. Ginecol Obstet Mex (1971) 0.75
Analysis of total, grouped, and individual urinary 17-ketosteroids: a critical evaluation. Acta Endocrinol (Copenh) (1971) 0.75
Precursors of urinary 11-oxy-17-ketosteroids. II. Allo-3 -tetrahydrocortisol. J Clin Endocrinol Metab (1971) 0.75
Effect of mestranol and chlormadinone acetate on urinary excretion of FSH and LH. Am J Obstet Gynecol (1968) 0.75
Inhibition of ovulation by estrogens. Am J Obstet Gynecol (1967) 0.75
Diurnal cycle of adrenal activity in secondary amenorrhea. Obstet Gynecol (1971) 0.75
The effect of formalin and the duration of acid hydrolysis on free and conjugated urinary 17-ketosteroids. Clin Chem (1968) 0.75